Polypharmacy in older adults is associated with multiple negative consequences that may
affect muscular function, independently from the presence of medical conditions. The aim of …

Background: Parkinson's disease (PD) and sarcopenia are two common diseases in aging
people. To date, the prevalence of sarcopenia in PD patients and the relationship between …

Background & aims There have been several attempts to come up with a global operational
definition of sarcopenia (S), and consequently, a definition of S has been established, to …

Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with
increasing age, being a major component in the development of frailty. Current knowledge …

Abstract Background The European Working Group on Sarcopenia in Older People
(EWGSOP) recently updated the definition and diagnostic criteria to assess sarcopenia …

Background Sarcopenia is associated with age-related loss of muscle mass and function
and is becoming prevalent in the older Chinese population. This systematic review aims to …

Background There is an increasingly strong association between sarcopenia and
malnutrition in research findings. We aimed to determine the prevalence and factors …

Physical activity (PA) has been identified as beneficial for many diseases and health
disorders, including sarcopenia. The positive influence of PA interventions on sarcopenia …

Methods The aim of this paper is to define terms commonly related to sarcopenia to enable
standardization of these terms in research and clinical settings. The Global Leadership …

Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and
function and associated with various adverse health outcomes. In this review, we aimed to …